Patents Assigned to CTI Vascular AG
-
Patent number: 11938286Abstract: The current document is directed to usable-length-selectable catheters that employ usable-length-selectable catheters to treat malformations, constrictions, obstructions, lesions, and blockages within patients' blood vessels. The usable length of the shaft of a usable-length-selectable catheter, to which the current application is directed, can be adjusted over a set of lengths prior to and during medical procedures.Type: GrantFiled: June 26, 2018Date of Patent: March 26, 2024Assignee: CTI VASCULAR AGInventors: Marc Gianotti, Ulf Fritz
-
Patent number: 11865279Abstract: The current document is directed to improved PTA methodologies that significantly decrease the risks of persistent blood-vessel-wall distention and subsequent restenosis and the risks of PTA-induced dissection, hematoma, and pseudoaneurysm when used to treat blood vessels. Similar improved percutaneous-transluminal-interventional methods are used to treat non-vascular vessels. The improved methods include initial selection of balloon length and inflation pressure for initial treatment of primary lesions to minimize the risks of over-inflation and generation of undesirable localized forces during balloon inflation. The improved methods further include higher-pressure treatment of remaining secondary lesions that also minimizes the risks of over-inflation and generation of undesirable localized forces. The improved methods can be practiced using differently sized balloons and conventional instrumentation, but may be facilitated by use of balloon-length-adjustable catheters.Type: GrantFiled: July 1, 2020Date of Patent: January 9, 2024Assignee: CTI Vascular AGInventors: Marc Gianotti, Lisa Gianotti, Stefan Richter
-
Publication number: 20230270680Abstract: The present disclosure is related to inorganic, biocompatible material compositions for bioactivatable devices, devices, and products comprising transition metal chalcogenides, such as molybdenum sulfides, that can be converted in vivo from a non-bioactive state to a bioactive state upon exposure to physiological conditions, wherein the bioactivated transition metal chalcogenide derivatives, such as molybdenum sulfide derivatives, exhibit copper-chelating activities. Various methods for the application of these compositions for enhancing biocompatibility and reducing or modulating copper-dependent biological reactions are provided.Type: ApplicationFiled: September 30, 2021Publication date: August 31, 2023Applicant: CTI Vascular AGInventors: Ulf FRITZ, Marc GIANOTTI
-
Publication number: 20220001149Abstract: The current document is directed to improved PTA methodologies that significantly decrease the risks of persistent blood-vessel-wall distention and subsequent restenosis and the risks of PTA-induced dissection, hematoma, and pseudoaneurysm when used to treat blood vessels. Similar improved percutaneous-transluminal-interventional methods are used to treat non-vascular vessels. The improved methods include initial selection of balloon length and inflation pressure for initial treatment of primary lesions to minimize the risks of over-inflation and generation of undesirable localized forces during balloon inflation. The improved methods further include higher-pressure treatment of remaining secondary lesions that also minimizes the risks of over-inflation and generation of undesirable localized forces. The improved methods can be practiced using differently sized balloons and conventional instrumentation, but may be facilitated by use of balloon-length-adjustable catheters.Type: ApplicationFiled: July 1, 2020Publication date: January 6, 2022Applicant: CTI Vascular AGInventors: Marc Gianotti, Lisa Gianotti, Stefan Richter
-
Publication number: 20210308432Abstract: The current document is directed to length-adjustable catheters and methods that employ length-adjustable catheters to treat malformations, constrictions, obstructions, lesions, and blockages within patients' blood vessels. The length of the shaft of a length-adjustable catheter, to which the current application is directed, can be adjusted over a range of lengths prior to and during medical procedures. In many implementations, length adjustment is accompanied by indications, to the medical provider, of the extent of a length adjustment. The indications may include one or more of visual markings, haptic feedback, radio-opaque markings, and/or other types of indications. In many implementations, the variable-length mechanism of the length-adjustable catheter is mechanically lockable following length adjustment.Type: ApplicationFiled: April 21, 2021Publication date: October 7, 2021Applicant: CTI Vascular AGInventors: Marc Gianotti, Michael Jetter, Martin Rickert, Dragana Gajic, Sabina Silva, Andreas Bodmer, Valentin Nickel, Ulf Fritz
-
Publication number: 20210077789Abstract: The current document is directed to usable-length-selectable catheters that employ usable-length-selectable catheters to treat malformations, constrictions, obstructions, lesions, and blockages within patients' blood vessels. The usable length of the shaft of a usable-length-selectable catheter, to which the current application is directed, can be adjusted over a set of lengths prior to and during medical procedures.Type: ApplicationFiled: June 26, 2018Publication date: March 18, 2021Applicant: CTI Vascular AGInventors: Marc GIANOTTI, Ulf FRITZ
-
Patent number: 10898696Abstract: A comprehensive multi-functional device platform that can be variably configured by clinician operators for patient-specific anatomies and clinical situations for treating complex and total occlusions is provided. This device platform enables physicians of any skill level to effectively treat the most challenging and complex lesions/occlusions more conveniently in less time. The Functionally Integratable Catheter System (“FICS System”) represents a system of “functional units” that can be configured together to operate synergistically, and comprises at least five main “functional units,” including: (a) FICS Support Catheter; (b) FICS Dilator; (c) FICS PTA Catheter; (d) FICS Lock-Grip Handle; and (e) FICS Steering Hub. Each “functional unit” can be provided in a pre-assembled form by the manufacturer, intended to be configured into variable combinations by clinician operators.Type: GrantFiled: January 11, 2016Date of Patent: January 26, 2021Assignee: CTI Vascular AGInventors: Marc Gianotti, Ulf Fritz, Dragana Gajic
-
Patent number: 10758717Abstract: A comprehensive multi-functional device platform that can be variably configured by clinician operators for patient-specific anatomies and clinical situations for treating complex and total occlusions is provided. This device platform enables physicians of any skill level to effectively treat the most challenging and complex lesions/occlusions more conveniently in less time. The Functionally Integratable Catheter System (“FICS System”) represents a system of “functional units” that can be configured together to operate synergistically, and comprises at least four main “functional units,” including: (a) FICS Support Catheter; (b) FICS Dilator; (c) FICS PTA Catheter; and (d) FICS Lock-Grip Handle. Each “functional unit” can be provided in a pre-assembled form by the manufacturer, intended to be configured into variable combinations by clinician operators.Type: GrantFiled: January 11, 2016Date of Patent: September 1, 2020Assignee: CTI Vascular AGInventors: Marc Gianotti, Ulf Fritz, Dragana Gajic
-
Patent number: 10688276Abstract: The current document is directed to length-adjustable catheters and methods that employ length-adjustable catheters to treat malformations, constrictions, obstructions, lesions, and blockages within patients' blood vessels. The length of the shaft of a length-adjustable catheter, to which the current application is directed, can be adjusted over a range of lengths prior to and during medical procedures. In many implementations, length adjustment is accompanied by indications, to the medical provider, of the extent of a length adjustment. The indications may include one or more of visual markings, haptic feedback, radio-opaque markings, and/or other types of indications. In many implementations, the variable-length mechanism of the length-adjustable catheter is mechanically lockable following length adjustment.Type: GrantFiled: August 26, 2015Date of Patent: June 23, 2020Assignee: CTI Vascular AGInventors: Marc Gianotti, Michael Jetter, Martin Rickert, Dragana Gajic, Sabina Silva, Andreas Bodmer, Valentin Nickel, Ulf Fritz
-
Publication number: 20200155816Abstract: The current document is directed to length-adjustable catheters and methods that employ length-adjustable catheters to treat malformations, constrictions, obstructions, lesions, and blockages within patients' blood vessels. The length of the shaft of a length-adjustable catheter, to which the current application is directed, can be adjusted over a range of lengths prior to and during medical procedures. In many implementations, length adjustment is accompanied by indications, to the medical provider, of the extent of a length adjustment. The indications may include one or more of visual markings, haptic feedback, radio-opaque markings, and/or other types of indications. In many implementations, the variable-length mechanism of the length-adjustable catheter is mechanically lockable following length adjustment.Type: ApplicationFiled: January 27, 2020Publication date: May 21, 2020Applicant: CTI Vascular AGInventors: Marc Gianotti, Michael Jetter, Martin Rickert, Dragana Gajic, Sabina Silva, Andreas Bodmer, Valentin Nickel, Ulf Fritz
-
Patent number: 10632005Abstract: The present invention relates to a catheter system and methods of using such catheter system for the treatment of vascular and non-vascular pathologies. More specifically, the present invention is directed towards a catheter system for the actuation of a temporarily implantable member elastically deformable by hydraulic means.Type: GrantFiled: December 14, 2016Date of Patent: April 28, 2020Assignee: CTI VASCULAR AGInventors: Marc Gianotti, Ulf Fritz
-
Publication number: 20190254846Abstract: Abstract: The present invention relates to a catheter system and methods of using such catheter system for the treatment of vascular and non-vascular pathologies. More specifically, the present invention is directed towards a catheter system for the actuation of a temporarily implantable member elastically deformable by hydraulic means.Type: ApplicationFiled: December 14, 2016Publication date: August 22, 2019Applicant: CTI Vascular AGInventors: Marc GIANOTTI, Ulf FRITZ
-
Publication number: 20180200489Abstract: A comprehensive multi-functional device platform that can be variably configured by clinician operators for patient-specific anatomies and clinical situations for treating complex and total occlusions is provided. This device platform enables physicians of any skill level to effectively treat the most challenging and complex lesions/occlusions more conveniently in less time. The Functionally Integratable Catheter System (“FICS System”) represents a system of “functional units” that can be configured together to operate synergistically, and comprises at least five main “functional units,” including: (a) FICS Support Catheter; (b) FICS Dilator; (c) FICS PTA Catheter; (d) FICS Lock-Grip Handle; and (e) FICS Steering Hub. Each “functional unit” can be provided in a pre-assembled form by the manufacturer, intended to be configured into variable combinations by clinician operators.Type: ApplicationFiled: January 11, 2016Publication date: July 19, 2018Applicant: CTI Vascular AGInventors: Marc Gianotti, Ulf Fritz, Dragana Gajic
-
Publication number: 20180200490Abstract: A comprehensive multi-functional device platform that can be variably configured by clinician operators for patient-specific anatomies and clinical situations for treating complex and total occlusions is provided. This device platform enables physicians of any skill level to effectively treat the most challenging and complex lesions/occlusions more conveniently in less time. The Functionally Integratable Catheter System (“FICS System”) represents a system of “functional units” that can be configured together to operate synergistically, and comprises at least four main “functional units,” including: (a) FICS Support Catheter; (b) FICS Dilator; (c) FICS PTA Catheter; and (d) FICS Lock-Grip Handle. Each “functional unit” can be provided in a pre-assembled form by the manufacturer, intended to be configured into variable combinations by clinician operators.Type: ApplicationFiled: January 11, 2016Publication date: July 19, 2018Applicant: CTI Vascular AGInventors: Marc Gianotti, Ulf Fritz, Dragana Gajic
-
Publication number: 20180154110Abstract: The current document is directed to length-adjustable catheters and methods that employ length-adjustable catheters to treat malformations, constrictions, obstructions, lesions, and blockages within patients' blood vessels. The length of the shaft of a length-adjustable catheter, to which the current application is directed, can be adjusted over a range of lengths prior to and during medical procedures. In many implementations, length adjustment is accompanied by indications, to the medical provider, of the extent of a length adjustment. The indications may include one or more of visual markings, haptic feedback, radio-opaque markings, and/or other types of indications. In many implementations, the variable-length mechanism of the length-adjustable catheter is mechanically lockable following length adjustment.Type: ApplicationFiled: August 26, 2015Publication date: June 7, 2018Applicant: CTI Vascular AGInventors: Marc Gianotti, Michael Jetter, Martin Rickert, Dragana Gajic, Sabina Silva, Andreas Bodmer, Valentin Nickel, Ulf Fritz